Nothing Special   »   [go: up one dir, main page]

Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: IEEE Trans Med Imaging. 2020 Feb 20;39(9):2760–2771. doi: 10.1109/TMI.2020.2975375

Patient-Specific Characterization of Breast Cancer Hemodynamics Using Image-Guided Computational Fluid Dynamics

Chengyue Wu 1, David A Hormuth II 2, Todd A Oliver 3, Federico Pineda 4, Guillermo Lorenzo 5, Gregory S Karczmar 6, Robert D Moser 7, Thomas E Yankeelov 8
PMCID: PMC7438313  NIHMSID: NIHMS1596458  PMID: 32086203

Abstract

The overall goal of this study is to employ quantitative magnetic resonance imaging (MRI) data to constrain a patient-specific, computational fluid dynamics (CFD) model of blood flow and interstitial transport in breast cancer. We develop image processing methodologies to generate tumor-related vasculature-interstitium geometry and realistic material properties, using dynamic contrast enhanced MRI (DCE-MRI) and diffusion weighted MRI (DW-MRI) data. These data are used to constrain CFD simulations for determining the tumor-associated blood supply and interstitial transport characteristics unique to each patient. We then perform a proof-of-principle statistical comparison between these hemodynamic characteristics in 11 malignant and 5 benign lesions from 12 patients. Significant differences between groups (i.e., malignant versus benign) were observed for the median of tumor-associated interstitial flow velocity (P = 0.028), and the ranges of tumor-associated blood pressure (P = 0.016) and vascular extraction rate (P = 0.040). The implication is that malignant lesions tend to have larger magnitude of interstitial flow velocity, and higher heterogeneity in blood pressure and vascular extraction rate. Multivariable logistic models based on combinations of these hemodynamic data achieved excellent differentiation between malignant and benign lesions with an area under the receiver operator characteristic curve of 1.0, sensitivity of 1.0, and specificity of 1.0. This image-based model system is a fundamentally new way to map flow and pressure fields related to breast tumors using only non-invasive, clinically available imaging data and established laws of fluid mechanics. Furthermore, the results provide preliminary evidence for this methodology’s utility for the quantitative characterization of breast cancer.

Index Terms: tumor, 1D-3D coupled, blood flow, interstitial fluid pressure, DCE-MRI, diffusion MRI

I. INTRODUCTION

It is well established that tumor initiation, growth, and invasion is tightly coupled to the characteristics of the available blood supply [1]. Additionally, interstitial flow within the tumor microenvironment determines access to nutrition, oxygen, and therapies for cells not immediately adjacent to vessels [2-7]. Both mechanisms contribute to heterogeneous delivery of therapeutics, leading to substantial variations of treatment response between patients. Increased interstitial flow also stimulates increased tumor cell migration and motility by activating cell surface receptors interacting with chemokines and the extracellular matrix [8][9]. Interstitial flow can exert a shear stress on tumor cells, resulting in G2/M arrest and inhibition of differentiation [10]. Interstitial fluid pressure also serves to activate tumor stroma and fibroblasts [11][12], and even increases angiogenesis [13]. Thus, being able to rigorously characterize, in vivo, tumor-associated hemodynamics and interstitial transport is important for quantifying several fundamental aspects of the underlying biology of cancer.

Currently, a tumor’s blood supply can be interrogated with a number of invasive or noninvasive techniques. Radioactive microspheres [14] and Doppler flowmetry [15] can provide accurate measurements of blood flow, but the techniques have found limited clinical application due to their invasive nature and their inability to interrogate deep tissues, respectively. Many non-invasive imaging techniques have been developed for measuring blood flow, including 15O-H2O positron emission tomography [16], Doppler ultrasound [17] and arterial spin labeling magnetic resonance imaging (MRI) [18]. While these techniques do provide important information on blood volume and flow rate, their accuracy, precision, and sensitivity are limited by the size of the vessels being imaged. Measurement of the interstitial environment is even more challenging. For example, using needle-based assessments, interstitial fluid pressure in malignant breast tumors has been found to be much higher than in benign or healthy conditions [19]. However, this measurement is invasive, has limiting sampling, and therefore cannot characterize any spatial heterogeneity that may exist. A recent development in the analysis of ultrasound elastography data provides a way to estimate fluid-related properties (e.g. vascular and interstitial permeability), based on reconstruction of mechanical parameters (Young’s modulus, Poisson’s ratio and strain time constant) [20-22]. This method is very attractive for its practical applicability. However, the heterogeneity in vascular geometry and the tumor microenvironment can be challenging to capture via ultrasound, which limits its compatibility with subsequent analyses of hemodynamic properties and drug delivery phenomena. MRI can potentially address these issues, and Liu et al. [23] characterized interstitial flow through pharmacokinetic analyses of dynamic contrast enhanced (DCE) MRI. In particular, they considered a spherical, well-organized tumor that consists of a highly perfused rim around a central necrotic core. The contrast agent bolus is assumed to be delivered into the tumor at the rim region and then spreads to the surrounding tissue. Therefore, while offering a practical implementation, these assumptions may represent an oversimplification of the underlying biology.

There have been also some recent efforts to utilize computational fluid dynamics (CFD) to characterize tumor related flow. For example, d’Esposito et al. [24] integrated a mathematical model describing steady-state blood and interstitial flow as well as solute delivery with optical imaging of fixed tumor samples. They then simulated the time-dependent delivery of agents and compared the delivery with that estimated via DCE-MRI. Kim et al. [25] used similar models employing x-ray computed tomography to define vessel and tissue structure. These studies significantly advanced the technique of in silico modeling of tumor-related fluid dynamics, as previous modeling approaches employed synthetic geometry to establish a tissue domain [26-30]. Critically, the above efforts all rely on segmenting vascular structures from ex vivo imaging data. This limits its utility for diagnosis or prognosis, because it 1) requires an invasive procedure that damages the system under investigation, and 2) provides limited information on the remaining lesion or host tissue. Furthermore, using predetermined constant values (population values) for material properties (e.g., vascular permeability and tissue hydraulic conductivity) cannot capture the inter- or intra-patient heterogeneity. Our goal is to extend these modeling approaches in a patient-specific and clinically feasible scenario.

In this contribution, we developed a CFD analysis of quantitative MRI data to characterize the hemodynamics of breast cancer on a patient-specific basis. We seek to extend these investigations to account for arbitrary tumor geometries by incorporating more patient-specific data into the modeling. Furthermore, we offer proof-of-principle data for the potential benefits of the approach on improving diagnostic accuracy. We posit that a more rigorous understanding of flow through tumor-associated vessels (i.e., those vessels that begin or end within the tumor) and its interaction with the surrounding interstitium will provide critical insights into diagnosis, delivery of therapy, as well as assessment and prediction of the response of breast tumors to treatment. To the best of our knowledge, this represents the first methodology of integrating computational fluid dynamics with patient specific MRI data for the mapping of the entire pressure and flow fields within the breast.

II. Theory and Methods

A. Image-Guided Computational System

The fluid system is modeled by a set of equations describing blood flow, interstitial transport, and their interaction throughout the entire breast. Central to the methodology, are the following four assumptions: 1) The blood flow within the vasculature is laminar; 2) The interstitial flow is laminar; 3) The exchange of fluid between plasma and interstitial space is due to the pressure difference across the vessel wall; 4) Spatial-resolved information regarding tissue properties can be extracted from MRI data. Detailed justification for each of these assumptions can be found in the supplemental materials.

The domain is divided into the vascular and interstitial space via segmentation of the high-spatial resolution MRI data. These regions are then assigned corresponding material properties via analyses of the DCE-MRI and diffusion-weighted MRI (DW-MRI) data. The simulation domain consists of two parts, the vessel network Ωv, and interstitial tissue, Ωt. We compute the blood flow within the vessel network along its centerlines, Λ, so that the vascular flow can be framed as a pseudo-1D problem, coupled to the 3D surrounding tissue [31][32].

We assume that blood flow through the vessel network follows Poiseuille’s law [32]:

Qv(l)=πR4(l)8μdpv(l)dl,,lΛ (1)

where l is the position along the vessel, Qv is the flux of blood, pv is the vascular pressure, R is the radius of vessel, and μ is the dynamic viscosity of blood (see Table I for a complete list of parameter symbols and definitions). The interstitial flow is described by Darcy’s law [32]:

ut(x)=κ(x)pt(x),xΩt (2)

where x is the coordinate in the 3D tissue domain, ut and pt are the interstitial flow velocity and pressure, respectively, and κ is the hydraulic conductivity of the interstitium. Finally, flux across the vascular walls is described by Starling’s law [32]:

qe(l)=Lp(l)[pv(l)pt,ev(l)],lΛ (3)

where qe is the rate of extravasation over a unit surface area, Lp is the vascular permeability, pt,ev is the pressure at the exterior vessel surface, averaged along the perimeter at the position l.

Table I.

Symbols for the computational fluid dynamics model

symbol Parameter (Units) Assignment
Ωt Interstitial tissue domain (−) 3D mesh generated from
images
Ωv Vascular region (−) 3D mesh generated from
images
Λ Vascular network (−) Pseudo-1D skeleton
generated from images
Qv Blood flow rate (cm3 s−1) Calculated based on Eq. (1)
pv Blood pressure (g cm−1 s−2) Calculated based on Eq. (6)
l Length / position along
vessels (cm)
Independent variable in FDM
R Vascular radius (cm) Scaled using vp
μ Blood dynamic viscosity
(g cm−1 s−1)
Assigned as constant 0.04,
based on literature [29][49]
ut Interstitial flow velocity
(cm s−1)
Calculated based on Eq. (2)
pt Interstitial pressure
(g cm−1 s−2)
Calculated based on Eq. (7)
x Coordinate in interstitial
tissue (cm×cm×cm)
Independent variable in FEM
κ Tissue hydraulic conductivity
(g−1 cm3 s)
Calibrated using ADC
(section II.B.4)
qe Net efflux across vessel wall
per unit surface area (cm s−1)
Calculated based on Eq. (3)
pt,ev Pressure at the exterior
surface of vessels (g cm−1 s−2)
Calculated from pt during
iteration
Lp Vascular permeability
(g−1 cm2 s)
Calibrated using Ktrans
(section II.B.4)

Conditions of continuity (flux and pressure) at the junction points of the vascular network and within the tissue region are summarized by Eqs. (4) - (8):

pvm,j=pvdk,j,j{junctionpoints} (4)
Qvm,j=k=1NdQvdk,j,j{junctionpoints} (5)
dQv(l)dl+2πR(l)qe(l)=0,lΛ (6)
ut(x)=0,xΩt (7)
nt(x)ut(x)=qe(l(x)),xΩtΩv (8)

where ∣m,j and ∣dk,j represent quantities at the jth junction point of the vessel network along the mother and kth daughter vessel respectively, with Nd,j being the total number of daughter vessels at the jth junction point, nt is the normal vector at the vascular exterior surface pointing from the tissue into the vessel, and l(x) is the position along the vessel network corresponding to the point x at the vascular exterior surface. A detailed explanation of the coupling of 1D and 3D coordinates can be found in the supplemental materials.

Using Eqs. (1) - (3) to eliminate the Qv, ut and qe in Eqs. (4) - (8), one arrives at the following system:

d2pvdl2+4RdRdldpvdl16μLpR3(pvpt,ev)=0,lΛ (10)

with for each j ∈ {junction points},

pvm,j=pvdk,j, (11)
R4m,jdpvdlm,j=k=1NdR4dk,jdpvdldk,j, (12)

and

(κ(x)pt(x))=0,xΩt (13)

with

nt(x)(κ(x)pt(x))=Lp(l(x)[pv(l(x))pt,ev(l(x))],xΩtΩv (14)

where Eqs. (10), (11) and (12) characterize the vasculature, and Eqs. (13) and (14) characterize the interstitial space.

B. Patient and MRI Data Acquisition

Twenty women with BI-RADS (Breast Imaging Reporting and Data System) 4 or 5 lesions identified on screening mammography, and with category C or D breast density, were recruited as part of an ongoing IRB-approved study to receive a research MRI prior to biopsy. Images from eight patients were excluded because no abnormal enhancement was found (four patients), or because the major breast vasculature was incompletely imaged due to a limited field of view (four patients). In total, 11 distinct malignant (invasive ductal carcinomas, and ductal carcinoma in situ) and 5 benign lesions (fibroadenomas) from 12 patients were identified.

MRI data were acquired on an Achieva 3T-TX (Philips, Netherlands) with a 16-channel bilateral breast coil. DCE–MRI was performed with a heavily T1-weighted, 3D spoiled gradient recalled echo protocol, consisting of one fat-suppressed, pre-contrast high-spatial resolution acquisition, five pre-contrast ultrafast acquisitions, and 16~20 post-contrast ultrafast acquisitions after the injection of 0.1 mM/kg MultiHance (Bracco, Milan), followed by four high-spatial resolution acquisitions. Pulse sequence parameters for the ultrafast scans were TR/TE/FA = 3.2 ms /1.6 ms /10° with a SENSE factor of 4 in the medial-lateral direction and 2 in the cranial-caudal direction, and a partial Fourier factor of 0.7 (in both ky and kz). The acquisition matrix and field-of-view were selected to yield a temporal resolution of 1.7~3.5 s and a spatial resolution of 1.5 × 1.5 × 4 mm3. Pulse sequence parameters for the high-spatial resolution scans were tR/TE/FA = 5.0 ms /2.5 ms /10° with SENSE of 2.5 in medial-lateral and partial Fourier of 0.85 in ky. The acquisition matrix and field of view were selected to yield a temporal resolution of approximately 55 s, and a spatial resolution of 0.8 × 0.8 × 1.6 mm3. Pre-contrast T1-weighted images were acquired with variable flip angles (5 and 15 degrees) with a spatial resolution of 1.0 × 1.0 × 1.6 mm3, so that pre-contrast T1 maps could be calculated and then down-sampled to match the ultrafast DCE-MRI. (Given the time constraints, B1 maps for correction of B1 inhomogeneities were not acquired [33][34][35].) DW-MRI data were acquired using a fat-suppressed, single-shot spin echo sequence with TR/TE = 13s / 67ms, and b-values of 0, 50, 800 s/mm2. The acquisition matrix and field-of-view were selected to yield a spatial resolution of 2 × 2 × 2.5 mm3. Example DCE-MRI and DW-MRI data can be found in the supplemental materials.

Prior to the analyses described below, a non-rigid, demons [36] registration was applied on the DCE-MRI data and calculated T1 map to minimize any patient motion that may occur during the acquisition. Briefly, the goal is to determine a spatial transformation that best aligns consecutive 3D image frames acquired during the dynamic scanning. To do so, we align each dynamic frame to the frame immediately previous to minimize the temporal gap between the reference and target images and, thus, any associated changes in image features. If the image acquired at time t is I(t), the deformation field, u, to transform I(t + 1) to I(t) is then computed via :

u=I(t+1)I(t)I(t)2+[I(t+1)I(t)]2I(t). (15)

A Gaussian filter with a standard deviation of 1.3 [37] is applied to u, yielding a smoothed deformation field which is then applied to the image to be registered, I(t + 1). The resulting deformed image is subsequently used to calculate the deformation field for the next set of time points. The calculation is performed iteratively with a Gaussian pyramid strategy [38] with three resolution levels. This strategy maximizes local registration accuracy, as well as global shape preservation. As indicated in the Matlab documentation, the deformation of I(t + 1) is executed with 500, 400 and 200 iterations at the lowest, medium and highest resolution, respectively [37].

C. Processing of Quantitative MRI Data

1). Segmentation and vessel detection

The registered, high spatial resolution DCE-MRI data were used for morphological analysis using a framework previously developed. While details are presented elsewhere [39], we briefly summarize the salient points. The lesions were segmented from the surrounding breast tissue using a fuzzy c-means clustering method [40]. (The same method was also adapted for segmentation of fibroglandular and adipose tissues.) Before vessel segmentation, histogram normalization and enhancement were performed by applying a local-statistics-based, intensity transfer function to the subtraction of the pre-from the post-contrast, high-spatial resolution images [41]. The 3D vasculature was then segmented from the surrounding tissue by applying a Hessian filter to the enhanced images [42], from which a probability for each voxel to belong to the vasculature was constructed. Finally, a lowest-cost tracking algorithm automatically detected vessels that have a high probability of contacting the lesion, as well as the path yielding the most likely physical connection between the vessel and tumor [39].

2). Pharmacokinetic modeling

The ultrafast DCE-MRI data were analyzed by a Patlak model [43] modified with a delayed bolus-arrival time (BAT):

Ct(t)=Ktrans0tCp(τ)dτ+vpCp(t), (16)
Cp(t)={0,0<tBATCp,pop(tBAT),t>BAT} (17)

where Ct (t) and Cp(t) are the time courses of the concentration of contrast agent in the tissue and the local plasma, respectively, and Cp,pop(t) is the population arterial input function measured from the internal thoracic arteries. Thus, the BAT, Ktrans (volume transfer coefficient, representing local vascular perfusion and permeability), and vp (plasma volume fraction) can be estimated for each voxel. More detailed explanation of the identification of Cp(t) and pharmacokinetic modeling can be found in [39]. Examples of DCE time courses and fitting can be found in the supplemental materials.

DW-MRI data were analyzed by standard methods [44] to yield parametric maps of the apparent diffusion coefficient (ADC). As the DW-MRI data were acquired with suppression of the fat signal (as is commonly done for DW-MRI of the breast), directly mapping the ADC values of that tissue component is challenging. Thus, for adipose tissue, a literature value (ADC = 1.91×10−5 mm2/s) was assigned to all voxels labeled as adipose tissue after segmentation [45]. In addition, a small number of unphysical ADC values (i.e., ADC values below 0.0 or above 3.0×10−3 mm2/s) may also exist in fibroglandular tissue due to signal noise. Thus, any voxels within the fibroglandular or tumor tissues displaying unphysical values were replaced by the average of their valid nearest-neighbor (i.e., 26 voxels in 3D). Finally, Gaussian smoothing with a standard deviation of 1.0 was applied at the edges of tissue regions to reduce unphysical discontinuities.

3). Vessel scaling and mesh generation

Numerical meshes of the whole breast including the lesion and vasculature were generated from segmented masks obtained from section II.C.1). Due to the relatively small radius of breast vessels compared to the imaging resolution, the directly segmented vessel mask suffers from significant partial volume effects and cannot accurately represent the size of vessels. Thus, an adaptive vessel scaling algorithm was designed by integrating information from the segmented vessel mask and the vp map.

First, the segmented vascular mask is skeletonized to its centerline (Fig. 2(a)). We identify the branching points, terminal ends, and vessel segments of the vascular network, and calculate orientations of each vessel. A gap filling process is applied with a similar strategy as the tumor-associated vessel tracking, so that the vascular network becomes a single connected graph. Furthermore, a moving average of length seven is applied to smooth the vessel centerlines. Second, the mask and vp map are up-sampled to an isotropic resolution of 200 microns (Fig. 2(b)). Third, at each specific location along the vessel centerline, a neighborhood in the up-sampled grid is identified using the vascular orientation and a step width dl of half of the up-sampled voxel size. This neighborhood represents the region in the original vessel mask covering the section of vessel at this location (Fig. 2(c)). We consider this section to be a cylinder with height dl and an unknown radius R, while its volume should be approximately equal to the vp value for this neighborhood multiplied by voxel volume in the refined grid:

πR2dl=i{identifiedneighborhood}vp(i)Vvox(i), (18)

where vp(i) is the measured plasma volume fraction for the ith voxel in this identified neighborhood, and Vvox(i) is the volume of the corresponding voxel, which is a constant 0.008 mm3.

Fig. 2.

Fig. 2.

Illustration for adaptive vessel scaling using vp map. Panel (a) illustrates the vessel skeleton after smoothing (red curve), the original segmented vessel mask (blue blocks) and vp values in corresponding voxels (yellow numbers) on a region containing a vessel (pink tube). The structures are up-sampled (green) in panel (b). Panel (c) indicates the neighborhood (deep blue blocks) identified with the local orientation of a vessel (v) and a predetermined step width (dl). Panel (d) indicates the vessel radius (R) calculated using Eq. (18) and the re-scaled vessel region mask (red blocks). Panel (e) shows the process going through the whole vessel. Panel (f) shows the result of vessel mask scaling (red blocks), which is compared with the original mask (baby blue blocks).

Eq. (18) enables the calculation of the local vascular radius. The voxels within the range of the cylinder with height dl and calculated radius R are considered the vascular region (Fig. 2(d)). The algorithm just described is applied stepwise to the entire vascular network to properly scale the vessel mask throughout the domain (Figs. 2(e) and 2(f)). Finally, a Matlab toolkit, iso2mesh [46], is used to convert the binary mask to surface and volumetric numerical meshes of the vasculature. The same toolkit is also used for generating meshes of the lesion and whole breast regions from their respective masks. The extravascular tissue mesh is then generated by applying the Boolean difference operation (‘surfboolean’ function in iso2mesh) between the breast contour and the vascular surfaces.

4). Parameter scaling

Parametric maps of ADC and Ktrans inform spatial-resolved (and patient-specific) values of tissue hydraulic conductivity, κ, and vascular permeability, Lp, respectively. We assume a simple linear scaling where the median of the scaled MRI parameter matches the median of the corresponding material property value from the literature.

5). Boundary conditions and direction of blood flow

Appropriate boundary conditions are necessary on both the boundaries of 3D tissue domain, ∂Ωt, as well as the terminal ends of pseudo-1D vascular network. Three subdomains of the tissue boundary are identified: 1) the surface contour of the breast, ∂Ωt,1, 2) the chest wall, ∂Ωt,2, and 3) the exterior surface of the vascular domain, ∂Ωt,3 = ∂Ωt∩∂Ωv. In this study, Dirichlet boundary condition for pressure (i.e., constant pressure pt = 2×104 g·cm−1·s−2) [31] is assigned on ∂Ωt,1 and ∂Ωt,2, and Neumann condition is assigned on ∂Ωt,3 (i.e., Eq. (14)).

The Dirichlet conditions on the pressure field at the terminal ends of the vascular network, as well as the direction of blood flow, are automatically determined using an optimization procedure modified from the work of Fry et al. [47]. Briefly, blood flow is first modeled with a simplifying assumption (i.e., non-permeable vessels and a uniform vascular radius) and randomly assigned flow directions. Because the boundary condition on the terminal ends is initially unknown, the simulation is implemented as an optimization process with flux continuity constraints at the vascular junction points. The optimization goal is to approach the target pressures at each node and the target shear stresses in each vessel segment. Thus, we minimize the object function L in Eq. (19):

L=0.5kpkN(0.5jSklj)(pv,kpv,0)2+0.5kτjSlj(τjτ0)2+iI(kNKikpv,k), (19)

with

Kik=δikjSiπrj8μlj(1δik)jSikπrj8μlj, (20)

where kp and kτ weight the relative contribution of the pressure and shear stress terms, respectively; pv,k is the pressure at the kth of N total vascular nodes; δik is the Kronecker delta; lj and τj are the length of and shear stress in the jth vessel segment, respectively, of S total vessels; Sk the set of vessels connected to kth node; and Sik the set of vessels connecting the ith and kth nodes. The third term in Eq. (19) arises through the constraint of flux continuity at the set of internal nodes, which are enforced with a standard Lagrange multiplier approach, where λi represents the Lagrange multiplier for the ith node. The target value of wall shear stress is set to be ∣τ0∣ = 15 g·cm−1·s−2, and target pressure pv,0 = 4.13 × 104 g·cm−1·s−2 [48]. The viscosity of blood, μ, is set to be 0.04 g·cm−1·s−1 [31][49].

After each iteration of this simulation, the bolus arrival-time, BAT(estimate), is then estimated and compared with the measured bolus arrival-time map, BAT(measure). Finally, simulated annealing (starting from a small kτ and doubling the ratio kτ/kp during each iteration to avoid biases toward the initial randomly assigned directions) is applied to adjust the assignment of flow directions until the normalized difference between BAT(estimate) and BAT(measure), M, is minimized; i.e., we minimize:

M=jS0lj[BATj(estimate)(l)BATj(measure)(l)]2dljS0lj[BATj(estimate)(l)BATj(measure)(l)]dl. (21)

This optimization procedure determines the flow direction and pressure at all terminal ends.

6). Numerical implementation

To numerically solve the 1D-3D coupled simulation system, (i.e., Eqs. (10) - (14)), an iterative algorithm which combines the finite difference method (FDM) and the finite element method (FEM) was implemented using the Python FEniCS library [50] as follows (definitions can be found in section II.A):

Step 1: Initialize pressure at exterior surface of vessel, pt,ev (0).

Step 2: Solve Eq. (10) for pv(1) with the FDM on the vessels,

2R(l)ΔldR(l)dl[pv(1)(l+1)pv(1)(l1)]16μLp(l)pv(1)(l)R(l)3+1Δl2[pv(1)(l+1)2pv(1)(l)+pv(1)(l1)]=16μLp(l)pt,ev(0)(l)R(l)3, (22)

where for each j ∈ {junction points},

pv(end)m,j=pv(0)dk,j=pvj, (23)
R4(end)m,jΔpv(end)m,jΔl=k=1NdR4(0)dk,jΔpv(0)dk,jΔl. (24)

Step 3: With the estimated pv(1) and Eq. (14), solve Eq. (13) for pt(1) using the FEM with tetrahedral elements and a test space of second-order, continuous, piecewise polynomials:

ΩtΩvLp(l(x))[pv(1)(l(x))pt,ev(1)(l(x))]v(x)dsΩtκ(x)pt(1)(x)v(x)dx,v{testfunctions} (25)

Step 4: Update pt,ev(1) by averaging the estimated pt(1) along the perimeter of vessel at position l.

Step 5: Repeat Steps 2 – 4, until pv(n), pt(n) converge according

topv(n)pv(n1)L2pv(n)L2pv(n1)L2+pt(n)pt(n1)L2pt(n)L2pt(n1)L2<ε=105.

Once this system (i.e., Eqs. (10) - (14)) is solved, it provides the fields of steady-state blood pressure, pv, and interstitial pressure, pt, throughout the domain. The local blood flow rate, Qv, and interstitial flow velocity, ut, can now be calculated based on Eqs. (1) and (2), respectively.

7). Computation time

The CFD simulation of each patient case takes approximately three minutes to converge on our lab’s server (CPU: 4× Intel Xeon E5-4627 v4 2.6GHz, 25M Cache, 8.0 GT/s; Memory: 256 GB), and approximately ten minutes on a standard laptop (MacBook Pro with CPU: 2.7GHz Intel Core i5, Memory: 8GB 1867MHz DDR3), even without using parallel solvers. The pre-processing are actually the major time-consuming steps, they include: calculating the T1 map, pharmacokinetic fitting, meshing of the 3D tissue domain, and defining the coupling relationship between 1D and 3D location coordinates. This takes approximately two hours for each patient with our current implementation. It should be noted, though, that these pre-processing steps are voxel- or node-wise computations, which can be directly parallelized. Further discussion on the robustness and uncertainty of the modeling pipeline, as well an assessment of error propagation from the input parameters to the computation outputs can be found in the supplemental materials.

D. Hemodynamic characterization and statistical analysis

The median and range (to assess potentially differences in intratumoral heterogeneity) of four hemodynamic characteristics are statistically compared between benign and malignant lesions: pv and qe along the tumor-associated vasculature, as well as pt and ∣ut∣ within the tumor regions. Additionally, we identify inlet and outlet vessels and calculate the total blood flow rate (total Qv) through the tumor for each lesion. More specifically, among the tumor-associated vessels, if the blood flow along a vessel begins outside and flows into the tumor, the vessel is defined as a “inlet”; if the blood flow along a vessel begins inside and then flows out of the tumor, the vessel is defined as an “outlet”. Thus, in total, nine metrics are to be investigated.

Spearman’s correlation coefficients are first calculated to determine the statistical relationship between the parameter pairs, so that the redundant parameter(s) (i.e., those for which ρ > 0.9) are excluded from further analyses. Furthermore, the Wilcoxon rank sum test is used to determine statistical differences (i.e., P < 0.05) in each parameter between malignant and benign lesions. The ability of all possible combinations of parameters to differentiate malignant from benign lesions is assessed by multivariable logistic regression modeling. Model performance is evaluated by receiver operating characteristic (ROC) analysis with leave-one-out cross-validation. Areas under the ROC curves (AUCs), as well as sensitivity and specificity at the optimal cutoff point determined by the maximum Youden’s index, are calculated for comparison.

III. RESULTS

A. Establishing the patient-specific domain

1). Image processing results

Fig. 3 shows the direct outputs of image processing for one example patient with a malignant lesion (panels (a) – (e)) and one example patient with a benign lesion (panels (f) – (j)). On the left side, panels (a) and (f) show 3D reconstructions of the vascular skeleton for the whole breast, lesions, and detected tumor-associated vessels. For the malignant lesion, seven tumor-associated vessels were detected, with one inlet and six outlets. The benign lesion has three tumor-associated vessels detected, with one inlet and two outlets. On the right side of the figure are the measured BAT (panels (b) and (g)), vp (panels (c) and (h)), Ktrans (panels (d) and (i)) and ADC (panels (e) and (j)) parametric maps in diseased breasts. The median of parameters for the example malignant tumor are BAT = 9.98 s, vp = 1.45×10−2, Ktrans = 0.34 min−1, and ADC = 1.15×10−3 mm2 s−1; parameters for the benign tumor are BAT = 11.10 s, vp = 1.00×10−4, Ktrans = 0.04 min−1 and ADC = 9.60×10−4 mm2 s−1.

Fig. 3.

Fig. 3.

Image analysis for the malignant (panels (a) – (e)) and benign (panels (f) – (j)) tumors. Panel (a) and (f) show the breast vasculature centerlines after smoothing and gap filling (black curves), on the segmented tumor lesions (gray volumes) and detected tumor-associated vessels (red curves for inlets and blue curves for outlets). Panels (b) and (g) depict the measured BAT map in the tumor and vessel regions on the central slice of tumor, overlaid on the post-contrast anatomical image. Panels (c) and (h) present the fitted vp map. Panels (d) and (i) show the Ktrans map. Panels (e) and (j) show ADC map after modification using method in section ii.C. 1. Note that the malignant lesion has more tumor-associated vessels, larger vp, larger Ktrans, and an earlier BAT compared to the benign lesion.

2). Mesh generation and material properties assignment

Fig. 4 presents the results of mesh generation and properties assignment for the example malignant (panels (a) – (d)) and the benign (panels (e) – (h)) cases respectively. Panels (a) and (e) visualize the numerical meshes of vasculature and the tumor regions. Ktrans maps are scaled to Lp and assigned to the vessel mesh (panels (c) and (g)). The literature values of Lp fall between 2.5×10−10 ~ 2.1×10−9 g−1 cm2 s with a median of 1.2×10−9 g−1 cm2 s [29][51]. The median of Ktrans within the breast vasculature for all patients is 0.16 min−1. Thus, a scalar coefficient of k1 = 7.6 × 10−9 is applied to scale the Ktrans values. Similarly, ADC maps are scaled to κ and assigned to the tissue mesh (panels (d) and (h)). The literature values of κ are between 10−12 ~ 10−10 g−1 cm3 s yielding a median value of 1.0 × 10−11 g−1 cm3 s [29][52]. The median of ADC for the whole breast tissue for all patients is 1.91×10−5 mm2 s−1. A scalar coefficient of k2 = 5.0 × 10−7 is applied to the ADC values.

Fig. 4.

Fig. 4.

Generation of meshes representing vasculature-interstitium geometry and assignment of spatial-resolved material properties for the malignant (first row) and benign (second row) tumors. Panels (a) and (e) present reconstructed vascular meshes (white volume) within the tumor region presented as purple, semi-translucent volumes. Panels (b) and (f) show the meshes of the interstitial tissue, where enlarged views show bifurcations of the excluded vessel region. Panels (c) and (g) map the vascular permeability (Lp) to the vessel meshes which is calibrated from Ktrans. Panels (d) and (h) assign the tissue hydraulic conductivity (κ) to the tissue meshes as calibrated from the ADC.

3). Automatic determination of the direction of blood flow

Fig. 5 illustrates the results of the hierarchical optimization procedure for determining the boundary condition at vascular terminal ends and the blood flow direction in the example patient with benign lesion. The objective function M reaches a minimal value of 0.61 at the 63th iteration of the optimization procedure (panel (a)). The resulting distribution of estimated BAT shows a DICE similarity of 0.83 with the measured BAT (panel (b)). Spatial-resolved BATs are visualized in panel (c).

Fig. 5.

Fig. 5.

Optimization procedure to automatically determine the direction of blood flow. Panel (a) shows the optimization object (M) plot over the simulated annealing process. Panel (b) compares the distribution of estimated (orange bars) and measured (blue bars) BAT values over the whole breast. Panel (c) displays the measured (left) and estimated (right) BAT onto the breast vasculature for visualization.

B. Visualization of flow simulation outputs

1). Whole breast pressure fields

Fig. 6 presents solutions of the image-based flow simulation for the diseased breasts of the two example patients. Panels (a) and (e) show the blood pressure along the vasculature network for the malignant and benign diseased breasts, respectively, where major inlet arteries (indicated by white arrows) from the posterior and lateral sections of the breasts can be identified via the color-coding. Panels (b) and (f) show the interstitial pressure fields in the breasts. Due to the significant efflux from vessel to breast tissue, regions close to the exterior surface of the major arterial inlets manifest high interstitial pressure, with the median and range of 2.01×104 (2.00×104 − 2.02×104) g·cm−1·s−2; while interstitial pressure close to the venous surface is generally low, with the median and range of 1.999×104 (1.995×104 − 2.000×104) g·cm−1·s−2, where influx from tissue back to vessels presents.

Fig. 6.

Fig. 6.

Simulation results in whole breast and tumor-associated region for the two example patients with malignant (panels (a) – (d)) and benign (panels (e) – (h)) tumors. Panels (a) and (e) present the blood pressure along the vascular network, with the tumor region presented as semi-translucent volumes. Panels (b) and (f) show the interstitial pressure in whole breast tissue, with the tumor region presented as well. Panels (c) and (g) show the interstitial pressure on the tumor surface. Panels (d) and (h) visualize the vector fields of interstitial flow velocity in the tumors, with the tumor volume presented as semi-translucent. Both the size and color of the arrows represent the magnitude of local velocity. The visualization demonstrates that the malignant lesion has higher and more heterogeneous interstitial pressure and interstitial flow velocity than the benign lesion.

2). Tumor interstitial pressure and flow velocity fields

Enlarged views of the interstitial pressure and flow velocity fields of the tumor are also shown in Fig. 6. Panels (c) and (g) present the pressure fields in the malignant and benign tumors, respectively. Comparing these two panels, the malignant lesion tends to have higher and wider range of interstitial pressure value; the median of pt for the malignant and benign tumors are 2.029×104 g·cm−1·s−2 and 2.015×104 g·cm−1·s−2, respectively. Panels (d) and (h) present the velocity vector fields in the malignant and benign tumors, with the arrow sizes scaled by the local vector magnitude. The magnitude of interstitial flow velocity in the benign tumor is smaller than that in the malignancy, where the median of ∣ut∣ for presented malignant and benign tumors are 7.72×10−8 cm·s−1 and 1.11×10−8 cm·s−1 respectively. In Fig. 6(d), obvious inward interstitial flow is indicated by the velocity vectors at the superior regions of the malignant tumor, where a major inlet artery contacts the lesion. Outward flow vectors are also observed at the inferior and anterior regions of the tumor, while flow is weak in the medial and posterior regions. Fig. 6(h) shows the interstitial flow in the benign tumor. (For movies showing the interstitial pressure and flow fields, please see the supplemental materials.)

C. Statistical analysis on hemodynamic characterization

1). Spearman’s correlation between parameters

With Spearman’s correlation test performed, only the range of tumor interstitial flow velocity (range ∣ut∣) is strongly correlated with other parameters. Specifically, ρ = 0.90, 0.92, and 0.95 for the correlations between the “range ∣ut∣” and “median pt”, “range qe” and “range pt”, respectively. Thus, the parameter “range ∣ut∣” is excluded from further statistical tests.

2). Wilcoxon test of each hemodynamic characteristic

As summarized in Table II, the median of tumor interstitial flow velocity (median ∣ut∣), range of blood pressure (range pv), and extraction rate (range qe) along the tumor-associated vessels, all have significant differences between malignant and benign lesions, based on the Wilcoxon test (P = 0.028, 0.016 and 0.040, respectively; see Fig. 7).

Table II.

Statistical comparison of parameters between benign and malignant lesions (n = 16)

Hemodynamic Parameters Median (range) P-value
(Wilcoxon)
Malignant (n = 11) Benign (n = 5)
median pt (×104 g·cm−1·s−2) 2.01 (2.00 – 2.07) 2.00 (2.00 – 2.02) 0.320
median ∣ut∣ (×10−8 cm·s−1) 1.69 (0.73 – 8.99) 0.71 (0.45 – 2.64) 0.028
median pv (×104 g·cm−1·s−2) 3.55 (1.88 – 4.39) 3.81 (2.76 – 4.77) 0.529
median qe (×10−8 cm·s−1) 1.81 (−0.28 – 16.85) 9.15 (2.88 – 13.90) 0.343
range pt (g·cm−1·s−2) 339.72 (31.62 – 3672.00) 36.79 (8.26 – 236.11) 0.090
range pv (×104 g·cm−1·s−2) 0.48 (0.26 – 2.46) 0.13 (0.03 – 0.40) 0.016
range qe (×10−8 cm·s−1) 28.00 (0.92 – 76.40) 4.39 (3.72 – 5.52) 0.040
total Qv (ml·(dl tissue)−1·min−1) 6.76 (0 – 63.59) 1.10 (0 – 14.43) 0.681
Fig. 7.

Fig. 7.

Box plots showing the hemodynamic characteristics which have significant differences between malignant and benign diseases. Panels (a – c) characterize the median of interstitial flow velocity magnitude (∣ut∣), range of blood pressure (pv) and range of vascular extraction rate (qe), respectively, On each box, the central mark indicates the median, and the bottom and top edges of the box indicate the 25th and 75th percentiles, respectively. The whiskers extend to the most extreme data points not considered outliers, and the outliers are plotted individually using the ‘+’ symbol.

3). ROC analysis to evaluate diagnostic performance

We use a multivariate regression model to assess the ability of the hemodynamic characteristics to separate malignant from benign disease. Among all possible combinations of the parameters, the model generated using a combination of {median of qe, median of ∣ut∣ and range of pv} performs the best. It achieves a sensitivity, specificity, and AUC of 1.0 in this proof-of-principle analysis.

IV. DISCUSSION

We have employed quantitative magnetic resonance imaging data to constrain a patient-specific, computational fluid dynamics model of blood flow and interstitial transport in breast cancer. The computational model is established based on Poiseuille’s law for blood flow in the vascular network, Darcy’s law for interstitial flow in the surrounding tissue, and Starling’s law for interaction between the blood plasma and interstitial fluid. Segmentations on high resolution contrast-enhanced images are used to generate 3D meshes and pseudo-1D vascular networks, which inform the modeling domains. Furthermore, quantitative MRI parameters (i.e., BAT, Ktrans, vp, and ADC) are adapted to refine the mesh, inform local material properties, and determine boundary conditions. The modeling system calibrated with patient-specific data is implemented with a coupled, 1D FDM – 3D FEM approach. The simulation directly provides solutions of blood and interstitial pressure fields, enabling calculation of blood flow velocity, blood flow rate, wall shear stress, extraction rate, and interstitial flow velocity.

The CFD analysis generates nine parameters to quantify hemodynamic characteristics associated with an individual tumor, among which eight are statistically uncorrelated and can be considered to contain complementary information. The statistical comparisons imply that, compared to benign lesions, malignant lesions tend to have larger magnitude of interstitial flow velocity, and greater heterogeneity of blood pressure and vascular extraction rate. The parameter combination characterizing tumor-associated interstitial flow velocity (median of ∣ut∣), vascular extraction rate (median of qe) and blood pressure (range of pv) provides excellent diagnostic sensitivity and specificity in this modest sample size. These results match with previous observations showing malignant tumors possess high interstitial fluid pressure [7], high vascular leakage [53], significant intratumoral heterogeneity in microenvironment [54] and high vascular perfusion [55][56].

We also compared our results with experimental measurements obtained from previous studies. For example, positron emission tomography measurements of 15O-labeled water have yielded a mean blood flow of 29.8 ± 17.0 (SD) ml/dl/min in breast carcinoma, and 5.6 ± 1.4 (SD) ml/dl/min for healthy breast tissue [56]. For the interstitial fluid pressure, Nathanson et al. [19] reported interstitial fluid pressure of (3.87 ± 0.40)×104 g cm−1 s−2 in invasive ductal carcinomas measured by needles inserted into lesions, and (0.48 ± 0.11) × 104 g cm−1 s−2 in benign breast tumors. Our analysis provides results on a similar scale but seem to be smaller than the invasively measured values, while the differences we found between malignant and benign lesions are, though, supported by Hathanson et al. Further validation experiments to support the proposed methods are of great interest. Specifically, we have an ongoing study on evaluating the effect of imaging quality (i.e., spatial resolution, signal-to-noise ratio, temporal resolution) on the proposed method’s accuracy and robustness using digital phantoms and virtual MRI data [57][58]. Experimental validation would require the use of invasive methods [19][56] to directly measure the hemodynamic characteristics in (for example) murine model of breast cancer which could then be compared to the outputs of our (or any other) noninvasive imaging-modeling workflow.

An advantage of our analyses is the ability to spatially resolve the interstitial flow fields of the tumor. For example, the malignant tumor in this study presents significant inward flow at the superior edge due to the localization of a major feeding artery, and outward flow on the inferior and anterior margins of the lesion; while the internal and posterior regions show much lower interstitial flow. As the association between interstitial flow and tumor progression remains an area of intense investigation [2-13], our visualization of these phenomena could provide additional, in vivo, information regarding invasion on an individual patient basis.

The proposed methodology could benefit from improvements in both the spatial and temporal resolution of DCE-MRI. For example, our Patlak analysis assumes zero backflow of contrast agent during the ultrafast DCE time courses. However, recent data [59] suggest contrast agent molecules could accumulate near the capillary due to slow diffusion, resulting in underestimation of Ktrans. Thus, more samples during the early portion of the DCE time course may be required. Additionally, the accuracy of the BAT measurement is limited by the temporal resolution and signal-to-noise ratio, which could adversely affect the determination of the vascular network boundary conditions. Furthermore, due to the current limits in spatial resolution, microvasculature cannot be fully identified. Specifically, the median of vascular radii identified in this proposed method is 135 μm, with an interquartile range of 104 – 188 μm. This scale approximately matches with that of tumor-related blood vessels visualized by photoacoustics [60]. However, it is still significantly larger than the scale of the radii of the capillary bed which is approximately 2.5 – 20 μm for normal microvessels, and 20 – 40 μm for dilated microvasculature within tumors [61]. To address these issues, we are currently developing partial k-space sampling and reconstruction techniques designed to dramatically improve the spatial and temporal resolution of 0.25 s [62]. The requirement for both high spatial and high temporal resolution data could limit the proposed methods’ routine application given the confines of the standard-of-care MRI exam. However, we are currently determining the methods’ sensitivity to resolution and signal-to-noise ratio via both simulations and experiments to balance the clinical restrictions and modeling reliability.

Another aspect to refine in this proposed model system is the calibration of tissue properties. In this report, we linearly scale the measured MRI parameters to inform model parameters; however, we acknowledge this approximation is almost certainly not optimal. For example, Tuch el al. [63] derived an approximately second-order relationship between ADC and the tissue conductivity κ. Similarly, Ktrans reflects the efflux rate of contrast agent from blood plasma into surrounding tissue, which not only depends on vascular permeability Lp, but also both local perfusion [64]. Further analyses to adapt more realistic relationships between MRI parameters and physiological properties should be investigated. Moreover, the situations of interface between lesions and background tissue are not considered in the current method. This is definitely of interest for future studies as well.

There are several additional future directions, refinements, and applications to explore. For example, as vascular and interstitial flow are known to vary during therapy, the parameters obtained with our modelling system could be used for monitoring or predicting treatment response. The modeling approach can be readily extended to characterize solute transport, so that dynamic delivery of oxygen, nutrients, or therapies through the circulation can also be estimated.

V. CONCLUSION

We have developed and implemented a computational model, informed by patient-specific magnetic resonance imaging data, to simulate the blood supply and interstitial fluid environment for breast tumors. Our results in the 16 cases (11 malignant and 5 benign lesions from 12 patients) indicate clear differences in hemodynamic characteristics between malignant and benign lesions. Specifically, malignant lesions tend to have larger magnitude of interstitial flow velocity, and greater heterogeneity in blood pressure and vascular extraction rate. These preliminary analyses suggest a fundamentally new way to employ contrast agent pharmacokinetics for the evaluation of breast cancer.

Supplementary Material

Supplemental

Fig. 1.

Fig. 1.

Flow chart of all processing steps. The computational model consists of a 1D-3D coupled computational fluid dynamic system and its numerical implementation. MRI data are passed through an image processing framework to generate patient-specific meshes and material properties, which are sequentially imported into the computational model. The model is constrained by patient-specific data to yield simulated solutions of tumor-related flow and pressure, which can then inform hemodynamic characteristics. The reader is encouraged to refer to this chart as they proceed through the text.

Acknowledgments

This work is supported by the National Cancer Institute through U01CA142565, U01CA174706, R01CA218700, R01CA172801 and P30CA014599, and the Cancer Prevention and Research Institute of Texas through RR160005. We offer our sincere thank you to all the women who volunteer to participate in our studies, your strength is a lesson for all of us.

Contributor Information

Chengyue Wu, Department of Biomedical Engineering, the University of Texas at Austin, Austin TX 78712 USA.

David A. Hormuth, II, Oden Institute for Computational Engineering and Sciences, and Livestrong Cancer Institutes, The University of Texas at Austin, Austin TX 78712 USA.

Todd A. Oliver, Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin TX 78712 USA

Federico Pineda, Department of Radiology, The University of Chicago, Chicago IL 60637 USA.

Guillermo Lorenzo, Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin TX 78712 USA.

Gregory S. Karczmar, Department of Radiology, The University of Chicago, Chicago, IL 60637 USA

Robert D. Moser, Department of Mechanical Engineering, and Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin TX 78712 USA

Thomas E. Yankeelov, Department of Biomedical Engineering, Department of Diagnostic Medicine, Department of Oncology, Oden Institute for Computational Engineering and Sciences, and Livestrong Cancer Institutes. The University of Texas at Austin, Austin TX 78712 USA. T.E.Y. is a CPRIT Scholar in Cancer Research.

REFERENCES

  • [1].Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989;49(23):6449–6465. [PubMed] [Google Scholar]
  • [2].Munson JM, Shieh AC. Interstitial fluid flow in cancer: implications for disease progression and treatment. Cancer Manag Res. 2014;6:317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Jain RK, Martin JD, Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu. Rev. Biomed. Eng 2014;16:321–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Swartz MA, Fleury ME. Interstitial flow and its effects in soft tissues. Annu Rev Biomed Eng. 2007;9:229–56. [DOI] [PubMed] [Google Scholar]
  • [5].Glicksman R, Chaudary N, Pintilie M, Leung E, Clarke B, Sy K, Hill RP, Han K, Fyles A, Milosevic M. The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP). Clin Transl Radiat. Oncol. 2017;6:15–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Baxter LT, Jain RK. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvas Res 1989;37(1):77–104. [DOI] [PubMed] [Google Scholar]
  • [7].Heldin CH, Rubin K, Pietras K, Östman A. High interstitial fluid pressure — an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806. [DOI] [PubMed] [Google Scholar]
  • [8].Kingsmore KM, Logsdon DK, Floyd DH, Peirce SM, Purow BW, Munson JM. Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms. Integr Biol. 2016;8(12):1246–60. [DOI] [PubMed] [Google Scholar]
  • [9].Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell. 2007;11(6):526–38. [DOI] [PubMed] [Google Scholar]
  • [10].Chang SF, Chang CA, Lee DY, Lee PL, Yeh YM, Yeh CR, Cheng CK, Chien S, Chiu JJ. Tumor cell cycle arrest induced by shear stress: Roles of integrins and Smad. Proc Natl Acad Sci. 2008;105(10):3927–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008;9(8):628. [DOI] [PubMed] [Google Scholar]
  • [12].Shieh AC, Rozansky HA, Hinz B, Swartz MA. Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Res. 2011:71(3):790–800. [DOI] [PubMed] [Google Scholar]
  • [13].Kim S, Chung M, Ahn J, Lee S, Jeon NL. Interstitial flow regulates the angiogenic response and phenotype of endothelial cells in a 3D culture model. Lab Chip. 2016;16(21):4189–99. [DOI] [PubMed] [Google Scholar]
  • [14].Prinzen FW, Bassingthwaighte JB. Blood flow distributions by microsphere deposition methods. Cardiovasc Res. 2000;45(1):13–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Zachos TA, Aiken SW, DiResta GR, Healey JH. Interstitial fluid pressure and blood flow in canine osteosarcoma and other tumors. Clin Orthop Relat Res. 2001;385:230–6. [DOI] [PubMed] [Google Scholar]
  • [16].Lodge MA, Jacene HA, Pili R, Wahl RL. Reproducibility of tumor blood flow quantification with 15O-water PET. J Nucl Med. 2008;49(10):1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Adler DD, Carson PL, Rubin JM, Quinn-Reid D. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol. 1990;16(6):553–9. [DOI] [PubMed] [Google Scholar]
  • [18].Kawashima M, Katada Y, Shukuya T, Kojima M, Nozaki M. MR perfusion imaging using the arterial spin labeling technique for breast cancer. J Magn Reson Imaging. 2012;35(2):436–40. [DOI] [PubMed] [Google Scholar]
  • [19].Nathanson SD, Nelson L. Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma. Ann Surg Oncol. 1994;1(4):333–8. [DOI] [PubMed] [Google Scholar]
  • [20].Islam MT, Tasciotti E, Righetti R. Non-invasive imaging of normalized solid stress in cancers in vivo. IEEE J Transl Eng He. 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Islam MT, Tasciotti E, Righetti R. Estimation of vascular permeability in irregularly shaped cancers using ultrasound poroelastography. IEEE Trans Biomed Eng. 2019. [DOI] [PubMed] [Google Scholar]
  • [22].Islam MT, Tang S, Liverani C, Tasciotti E, Righetti R. Non-invasive imaging of Young's modulus and Poisson's ratio in cancers in vivo. arXiv preprint arXiv:1809.02929. 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Liu LJ, Brown SL, Ewing JR, Ala BD, Schneider KM, Schlesinger M. Estimation of Tumor Interstitial Fluid Pressure (TIFP) Noninvasively. PloS One. 2016;11(7):e0140892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].d’Esposito A, Sweeney PW, Ali M, Saleh M, Ramasawmy R, Roberts TA, Agliardi G, Desjardins A, Lythgoe MF, Pedley RB, Shipley R. Computational fluid dynamics with imaging of cleared tissue and of in vivo perfusion predicts drug uptake and treatment responses in tumours. Nat Biomed Eng. 2018;2(10):773. [DOI] [PubMed] [Google Scholar]
  • [25].Kim E, Stamatelos S, Cebulla J, Bhujwalla ZM, Popel AS, Pathak AP. Multiscale imaging and computational modeling of blood flow in the tumor vasculature. Ann Biomed Eng. 2012;40(11):2425–2441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Stamatelos SK, Kim E, Pathak AP, Popel AS. A bioimage informatics based reconstruction of breast tumor microvasculature with computational blood flow predictions. Microvasc Res. 2014;91:8–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Sefidgar M, Soltani M, Bazmara H, Mousavi M, Bazargan M, Elkamel A. Interstitial flow in cancerous tissue: effect of considering remodeled capillary network. J Tissue Sci Eng. 2014;S4:2. [Google Scholar]
  • [28].Soltani M, Chen P. Numerical modeling of interstitial fluid flow coupled with blood flow through a remodeled solid tumor microvascular network. PloS One 2013;8(6):e67025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Pozrikidis C. Numerical simulation of blood and interstitial flow through a solid tumor. J Math Biol. 2010;60(1):75–94. [DOI] [PubMed] [Google Scholar]
  • [30].Welter M, Rieger H. Interstitial fluid flow and drug delivery in vascularized tumors: a computational model. PloS One. 2013;8(8):e70395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Sun Q, Wu GX. Coupled finite difference and boundary element methods for fluid flow through a vessel with multibranches in tumours. Int J Numer Method Biomed Eng. 2013;29(3):309–331. [DOI] [PubMed] [Google Scholar]
  • [32].D'Angelo C, Afio Q. On the coupling of 1d and 3d diffusion-reaction equations: application to tissue perfusion problems. Math Models Methods Appl Sci. 2008;18(8):1481–1504. [Google Scholar]
  • [33].Whisenant JG, Dortch RD, Grissom W, Kang H, Arlinghaus LR, Yankeelov TE. Bloch-Siegert B1-Mapping Improves Accuracy and Precision of Longitudinal Relaxation Measurements in the Breast at 3T. Tomography. 2016;2(4):250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Bane O, Hectors SJ, Wagner M, Arlinghaus LL, Aryal MP, Cao Y, Chenevert TL, Fennessy F, Huang W, Hylton NM, Kalpathy-Cramer J. Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study. Magn Reason Med. 2018;79(5):2564–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Sorace AG, Wu C, Barnes SL, Jarrett AM, Avery S, Patt D, Goodgame B, Luci JJ, Kang H, Abramson RG, Yankeelov TE. Repeatability, reproducibility, and accuracy of quantitative MRI of the breast in the community radiology setting. J Magn Reson Imaging. 2018;48(3):695–707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Thirion JP, Image matching as a diffusion process: an analogy with Maxwell's demons. Med Image Anal. 1998;2(3):243–60. [DOI] [PubMed] [Google Scholar]
  • [37].MATLAB and Image Processing Toolbox: User’s Guide (R2016a), The MathWorks, Inc., Natick, Massachusetts, United States. [Google Scholar]
  • [38].Thevenaz P, Ruttimann UE, Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process. 1998;7(1):27–41. [DOI] [PubMed] [Google Scholar]
  • [39].Wu C, Pineda F, Hormuth DA, Karczmar GS, Yankeelov TE. Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors. Magn Reason Med. 2019;81(3):2147–2160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Chen W, Giger ML, Bick U. A Fuzzy C-Means (FCM)-Based Approach for Computerized Segmentation of Breast Lesions in Dynamic Contrast-Enhanced MR Images. Acad Radiol. 2006;13(1):63–72. [DOI] [PubMed] [Google Scholar]
  • [41].Yu Z, Bajaj C. “A fast and adaptive method for image contrast enhancement,” in Intl Conf on Image Processing 2004;2:1001–1004 [Google Scholar]
  • [42].Vignati A, Giannini V, Bert A, Borrelli P, Luca MD, Martincich L, Sardanelli F, Regge D. A Fully Automatic Multiscale 3-Dimensional Hessian-Based Algorithm for Vessel Detection in Breast DCE-MRI. Invest Radiol. 2012;47(12):705–710. [DOI] [PubMed] [Google Scholar]
  • [43].Yankeelov TE, Gore JC, Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev. 2007;3(2):91–107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Woodhams R, Ramadan S, Stanwell P, Sakamoto S, Hata H, Ozaki M, Kan S, Inoue Y. Diffusion-weighted imaging of the breast: principles and clinical applications. Radiographics. 2011;31(4): 1059–84. [DOI] [PubMed] [Google Scholar]
  • [45].Steidle G, Eibofner F Schick F. Quantitative diffusion imaging of adipose tissue in the human lower leg at 1.5T. Magn Reson Med. 2011;65(4):1118–24. [DOI] [PubMed] [Google Scholar]
  • [46].Fang Q, Boas DA. “Tetrahedral mesh generation from volumetric binary and grayscale images,” in Proc IEEE Int Symp Biomed Imaging, 2009;1142–1145. [Google Scholar]
  • [47].Fry BC, Lee J, Smith NP, Secomb TW. Estimation of blood flow rates in large microvascular networks. Microcirculation. 2012;19(6):530–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Pries AR, Secomb TW, Gaehtgens P. Biophysical aspects of blood flow in the microvasculature. Cardiovasc Res. 1996;32:654–667. [PubMed] [Google Scholar]
  • [49].Pedley TJ. The fluid mechanics of large blood vessels (Cambridge Monographs on Mechanics). Cambridge, Cambridge University Press; 1980. [Google Scholar]
  • [50].Logg A, Mardal KA, Wells G. Automated Solution of Differential Equations by the Finite Element Method: the FEniCS book. Springer, 2012. [Google Scholar]
  • [51].Baish JW, Netti PA, Jain RK. Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. Microvasc Rese. 1997:53(2):128–141. [DOI] [PubMed] [Google Scholar]
  • [52].Swabb EA, Wei J, Gullino PM. Diffusion and Convection in Normal and Neuplastic Tissues”, Cancer Res. 1974;34(10):2814–2822. [PubMed] [Google Scholar]
  • [53].Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1–2):271–84. [DOI] [PubMed] [Google Scholar]
  • [54].Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011;121(10):3786–3788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [55].Beaney R, Jones T, Lammertsma A, Mckenzie C, Halnan K. Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet. 1984;323(8369):131–134. [DOI] [PubMed] [Google Scholar]
  • [56].Wilson CB, Lammertsma AA, McKenzie CG, Sikora K, Jones T. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. Cancer Res. 1992;52(6):1592–1597. [PubMed] [Google Scholar]
  • [57].Wu C, Hormuth DA, Oliver TA, Pineda F, Karczmar GS, Moser RD, Yankeelov TE. A dynamic digital phantom with realistic vasculature and perfusion based on MR histology. ISMRM 28th annual meeting, Sydney, Australia April 2020. Abstract #2822 [Google Scholar]
  • [58].Wu C, Easley T, Eijkhout V, Hormuth DA, Pineda F, Karczmar GS, Yankeelov TE. Validation of dynamic contrast-enhanced MRI analyses via virtual MRI simulation on a dynamic digital phantom. ISMRM 28th annual meeting, Sydney, Australia April 2020. Abstract #2827 [Google Scholar]
  • [59].Woodall RT, Barnes SL, Hormuth DA, Sorace AG, Quarles CC, Yankeelov TE. The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains. Magn Reson Med. 2018;80(1):330–340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Toi M, Asao Y, Matsumoto Y, Sekiguchi H, Yoshikawa A, Takada M, Kataoka M, Endo T, Kawaguchi-Sakita N, Kawashima M, Fakhrejahani E. Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array. Sci Rep. 2017;7:41970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [61].Senchukova MA, Nikitenko NV, Tomchuk ON, Zaitsev NV, Stadnikov AA. Different types of tumor vessels in breast cancer: morphology and clinical value. Springerplus. 2015;4(1):512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [62].Easley TO, Pineda F, Kim B, Foygel-Barber R, Wu C, Yankeelov TE, Fan X, Sheth D, Schacht D, Abe H, Karczmar GS. “A new approach to quantitative measurement of breast tumor blood flow capillary permeability,” in Proc Intl Soc Magn Reson Med 27 2019; Abstract #2262. [Google Scholar]
  • [63].Tuch DS, Wedeen VJ, Dale AM, George JS, Belliveau JW. Conductivity tensor mapping of the human brain using diffusion tensor MRI. Proc Natl Acad Sci. 2001;98(20):11697–11701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].Carson E, Cobelli C. Modeling Methodology for Physiology and Medicine. Newnes, 2001, Chapter17, pp. 373–401. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental

RESOURCES